The simultaneous treatment of DN and OA on A549 cells has, therefore, simultaneously diminished cell proliferation while stimulating apoptosis by blocking the FAK/STAT3 signaling pathway, indicating that the current combination might represent an attractive prospective therapeutic strategy for the management of lung cancer. The gene discussed is PTK2; the disease is lung cancer.